↓ Skip to main content

New Psychoactive Substances

Overview of attention for book
Cover of 'New Psychoactive Substances'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 83 Bioanalytical Methods for New Psychoactive Substances
  3. Altmetric Badge
    Chapter 102 Toxicokinetics of NPS: Update 2017
  4. Altmetric Badge
    Chapter 107 Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
  5. Altmetric Badge
    Chapter 110 Fatal Poisonings Associated with New Psychoactive Substances
  6. Altmetric Badge
    Chapter 111 Wastewater Analysis for Community-Wide Drugs Use Assessment
  7. Altmetric Badge
    Chapter 113 Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances
  8. Altmetric Badge
    Chapter 124 Phencyclidine-Based New Psychoactive Substances
  9. Altmetric Badge
    Chapter 127 Emergence, Diversity, and Control of New Psychoactive Substances: A Global Perspective
  10. Altmetric Badge
    Chapter 134 Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project
  11. Altmetric Badge
    Chapter 135 Patterns of Acute Toxicity Associated with New Psychoactive Substances
  12. Altmetric Badge
    Chapter 143 The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins
  13. Altmetric Badge
    Chapter 144 The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution
  14. Altmetric Badge
    Chapter 148 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances
  15. Altmetric Badge
    Chapter 149 Synthetic Opioids
  16. Altmetric Badge
    Chapter 154 Designer Benzodiazepines: Another Class of New Psychoactive Substances
  17. Altmetric Badge
    Chapter 160 Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures
  18. Altmetric Badge
    Chapter 177 Self-Experiments with Psychoactive Substances: A Historical Perspective
  19. Altmetric Badge
    Chapter 178 Neuropharmacology of Synthetic Cathinones
Attention for Chapter 110: Fatal Poisonings Associated with New Psychoactive Substances
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

10 X users
1 Facebook page


22 Dimensions

Readers on

50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Fatal Poisonings Associated with New Psychoactive Substances
Chapter number 110
Book title
Handbook of Experimental Pharmacology
Published in
Handbook of experimental pharmacology, August 2018
DOI 10.1007/164_2018_110
Pubmed ID
Book ISBNs
978-3-03-010560-0, 978-3-03-010561-7

Robert Kronstrand, Davide Guerrieri, Svante Vikingsson, Ariane Wohlfarth, Henrik Gréen, Kronstrand, Robert, Guerrieri, Davide, Vikingsson, Svante, Wohlfarth, Ariane, Gréen, Henrik


This chapter describes how new psychoactive substances (NPS) have been involved in fatal intoxications from 2010 and onwards. It summarizes the circumstances, antemortem symptoms, and adverse effects that have led to death after ingestion of one or more NPS and tabulates concentrations, and postmortem findings from these intoxications.Consumption of NPS exerts health problems and unknown risks for the users. Data on toxicity of many NPS are scarce or nonexistent and long-term toxicity and risks are still largely unknown. In addition, purity and composition of products containing NPS are often inconsistent or not known, which places users at high risk as evidenced by hospital emergency admissions and deaths.The most serious threat to drug users are the synthetic opioids that with strong central nervous depressant effects have caused numerous accidental deaths spread over the entire globe. The synthetic cannabinoids seem to be the most unpredictable with no clear toxidrome and unknown or poorly understood mechanisms of toxicity, but with adverse effects pointing toward the cardiovascular system. The toxidromes commonly encountered after ingestion of cathinones and phenethylamines are of sympathomimetic and hallucinogenic character, which includes risk of developing a serotonin syndrome, excited delirium, and life-threatening cardiovascular effects. In comparison to their conventional "parent" drug, i.e., heroin, cannabis, and amphetamine, most NPS appear to exhibit more severe adverse effects. The deaths attributed to NPS have dramatically increased in the last years. In our opinion, this is because of the shift from synthetic cannabinoids and cathinones to the even more toxic and dangerously potent fentanyl analogues.

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 50 100%

Demographic breakdown

Readers by professional status Count As %
Other 6 12%
Student > Bachelor 6 12%
Student > Ph. D. Student 6 12%
Researcher 6 12%
Student > Postgraduate 6 12%
Other 8 16%
Unknown 12 24%
Readers by discipline Count As %
Medicine and Dentistry 19 38%
Pharmacology, Toxicology and Pharmaceutical Science 7 14%
Chemistry 6 12%
Agricultural and Biological Sciences 2 4%
Social Sciences 1 2%
Other 3 6%
Unknown 12 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2022.
All research outputs
of 23,775,451 outputs
Outputs from Handbook of experimental pharmacology
of 658 outputs
Outputs of similar age
of 332,167 outputs
Outputs of similar age from Handbook of experimental pharmacology
of 10 outputs
Altmetric has tracked 23,775,451 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 658 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.1. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 332,167 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.